| abstract |
The present application provides fusion proteins comprising a cytokine fused to an albumin binding moiety. The fusion protein may also include an antigen binding moiety such as a therapeutic antibody. Methods of making and using the fusion proteins are also provided. The present application also provides methods of treatment comprising administering a fusion protein comprising a cytokine fused to a half-life extending domain and a second agent. |